Sindiani A, Obeidat B, Hamadeh L, Alghazo S, Al-Mohtaseb A, Alshdaifat E. A descriptive study of the clinico-pathological and surgical characteristics of patients with
primary epithelial ovarian cancer. A cross sectional study.
Ann Med Surg (Lond) 2020;
59:254-257. [PMID:
33101665 PMCID:
PMC7569166 DOI:
10.1016/j.amsu.2020.09.043]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2020] [Revised: 09/27/2020] [Accepted: 09/29/2020] [Indexed: 11/18/2022] Open
Abstract
Objective
To study the clinical, pathological and surgical features of primary epithelial ovarian cancer treated at our institution.
Methods
fifty-nine patients with primary epithelial ovarian cancer were included. Clinical data collected included patient's age, presenting symptoms, laboratory and tumor markers results as well as preoperative imaging reports. Pathological and surgical findings included were: spread of the disease, histologic type, stage of the disease, type of surgical procedure and amount of residual disease.
Results
Mean age of the patients was 54.5 years. Lower abdominal pain was the most common presenting symptom, followed by abdominal distension. The commonest histopathological type was high grade serous carcinoma (72.9%). In our study, majority of patients were diagnosed with stage III disease, accounting for 69.5% of the total number of patients. Complete cytoreduction with no gross residual disease was achieved in 77.3% of patients with stage 3–4 disease.
Conclusion
clinical and pathological features of primary epithelial ovarian carcinoma in our populations are similar to what is reported worldwide. We have also documented that our surgical approach to the management of ovarian cancer is comparable to the international consensus.
The commonest histopathological type of ovarian cancer in our institute is high grade serous carcinoma (72.9%).
In our study, majority of patients were diagnosed with stage III disease, accounting for 69.5% of the total number of patients.
Complete cytoreduction with no gross residual disease was achieved in 77.3% of patients with stage 3–4 disease.
We have reported a high complete cytoreduction rate (77.3%).
Collapse